Lymphogranuloma venereum risk factors: Difference between revisions
Jump to navigation
Jump to search
m (Changes made per Mahshid's request) |
|||
| Line 16: | Line 16: | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Gynecology]] | [[Category:Gynecology]] | ||
[[Category:Needs content]] | [[Category:Needs content]] | ||
[[Category:Bacterial diseases]] | [[Category:Bacterial diseases]] | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
Latest revision as of 18:00, 18 September 2017
|
Lymphogranuloma venereum Microchapters |
|
Differentiating Lymphogranuloma venereum from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Lymphogranuloma venereum risk factors On the Web |
|
American Roentgen Ray Society Images of Lymphogranuloma venereum risk factors |
|
Risk calculators and risk factors for Lymphogranuloma venereum risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nate Michalak, B.A.
Overview
Risk factors for developing lymphogranuloma venereum include HIV-positive serostatus, unprotected sexual intercourse (anal intercourse higher risk than vaginal intercourse) and multiple sex partners.
Risk Factors
- Unprotected anal intercourse is a greater risk factor than unprotected vaginal intercourse
- Multiple sex partners[2]
References
- ↑ Ward H, Martin I, Macdonald N, Alexander S, Simms I, Fenton K; et al. (2007). "Lymphogranuloma venereum in the United kingdom". Clin Infect Dis. 44 (1): 26–32. doi:10.1086/509922. PMID 17143811.
- ↑ Ceovic R, Gulin SJ (2015). "Lymphogranuloma venereum: diagnostic and treatment challenges". Infect Drug Resist. 8: 39–47. doi:10.2147/IDR.S57540. PMC 4381887. PMID 25870512.